Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.133EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.489EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.363EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.95EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.531EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.200EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.299EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.149EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.300EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.179EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.125EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
G.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.197EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.491EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.8 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used